Skip to main content

ProThera, Inc. dba SFI USA Recall: Small quantity of product labeled as Melatonin Lozenge Formula were filled with L-Theanine.

United States

TerminatedClass III

Company
ProThera, Inc. dba SFI USA
Product
Klaire Labs Melatonin Lozenge Formula Fast Dissolving 1 mg…
Recall date
January 17, 2019
Terminated
March 26, 2019
Source
FDA

Reason for recall

Small quantity of product labeled as Melatonin Lozenge Formula were filled with L-Theanine.

  1. - Recall initiated
  2. - Reported by source
  3. - Recall terminated
Recalled products
Product description UPC Quantity Lot / code information
Klaire Labs Melatonin Lozenge Formula Fast Dissolving 1 mg tablets; Packed in a 75 cc HDPE Bottle 60 Tablets UPC: 8 28054 17845 8; SKU: ML1 Not published in this source record 120 bottles FG Lot 2018410057; Expiration Date 8/2020

Distribution

  • One customer in KS.

Official source record

Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
F-1101-2019
Event ID
82010
Status
Terminated
Classification
Class III
Company
ProThera, Inc. dba SFI USA
Product description
Klaire Labs Melatonin Lozenge Formula Fast Dissolving 1 mg tablets; Packed in a 75 cc HDPE Bottle 60 Tablets UPC: 8 28054 17845 8; SKU: ML1
Quantity
120 bottles
Reason
Small quantity of product labeled as Melatonin Lozenge Formula were filled with L-Theanine.
Recall initiation date
January 17, 2019
Report date
March 6, 2019
Classification date
Not published in this source record
Termination date
March 26, 2019
Distribution pattern
One customer in KS.
UPC, lot, and code information
FG Lot 2018410057; Expiration Date 8/2020
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date

Responsible company: ProThera, Inc. dba SFI USA

Other recalls from ProThera, Inc. dba SFI USA

FDA Recall United States Terminated Historical recordClass II

ProThera, Inc. dba SFI USA

Product
Klaire Labs Reduced L-Glutathione 150 mg capsules, single…
Published
April 3, 2019
Distribution
US distribution to the following: AL, AZ…

View recall →

Distribution map

A map highlighting the states named in the source's distribution description.

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map
State Distributed
Kansas 1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class III mean?

A situation in which use of or exposure to a product is not likely to cause adverse health consequences.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.